首页 > 最新文献

Drugs of The Future最新文献

英文 中文
Lisavanbulin. Microtubule destabilizer (tubulin polymerization inhibitor), Tumor checkpoint controller, Treatment of advanced glioblastoma multiforme Lisavanbulin。微管不稳定剂(微管蛋白聚合抑制剂)，肿瘤检查点控制器，多形性晚期胶质母细胞瘤的治疗
IF 0.2 4区 医学 Q4 Medicine
Drugs of The Future
Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.9.3417140
C. Tiu, J. López
{"title":"Lisavanbulin. Microtubule destabilizer (tubulin polymerization inhibitor), Tumor checkpoint controller, Treatment of advanced glioblastoma multiforme","authors":"C. Tiu, J. López","doi":"10.1358/dof.2022.47.9.3417140","DOIUrl":"https://doi.org/10.1358/dof.2022.47.9.3417140","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66445381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sabatolimab. TIM-3-targeting monoclonal antibody, Treatment of myelodysplastic syndrome, Treatment of acute myeloid leukemia Sabatolimab。tim -3靶向单克隆抗体，治疗骨髓增生异常综合征，治疗急性髓性白血病
IF 0.2 4区 医学 Q4 Medicine
Drugs of The Future
Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.5.3378054
M. Ussowicz
{"title":"Sabatolimab. TIM-3-targeting monoclonal antibody, Treatment of myelodysplastic syndrome, Treatment of acute myeloid leukemia","authors":"M. Ussowicz","doi":"10.1358/dof.2022.47.5.3378054","DOIUrl":"https://doi.org/10.1358/dof.2022.47.5.3378054","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66444048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
American Chemical Society - 263rd National Meeting and Exposition. Virtual/San Diego - March 20-24, 2022 美国化学学会第263届全国会议暨博览会。虚拟/圣地亚哥——2022年3月20-24日
IF 0.2 4区 医学 Q4 Medicine
Drugs of The Future
Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.5.3432776
A. Fernández-Llamazares, S.K. Chadrasekaran, P. Cole, X. Bofill
The American Chemical Society (ACS)'s National Meeting and Exposition is a premier networking and education event for the global chemistry community, with an astounding program of scientific sessions covering all fields of chemistry. The 263rd edition of ACS meeting, with the theme 'Bonding through chemistry,' was held both on site at the San Diego Convention Center and virtually allowing for an almost return to normal meeting attendance since the start of the COVID-19 pandemic. The meeting spanned over 5 days of sessions comprising 11,359 s programmed with 9,282 in-person registrants and 3,284 virtual registrants. Posters and oral presentations were either in person, virtual or both, with live interaction possible either in a room and/or online. This report highlights some of the medicinal chemistry presentations delivered at the meeting. © 2022 Prous Science. All rights reserved.
美国化学会(ACS)的全国会议和博览会是全球化学社区的首要网络和教育活动，具有涵盖化学所有领域的令人震惊的科学会议计划。第263届ACS会议以“通过化学建立联系”为主题，在圣地亚哥会议中心现场举行，并几乎恢复了自COVID-19大流行开始以来的正常会议出席率。会议为期5天，共有11359次会议，9282人亲自登记，3284人虚拟登记。海报和口头演讲可以是面对面的，也可以是虚拟的，或者两者兼而有之，可以在房间和/或在线进行现场互动。本报告重点介绍了在会议上发表的一些药物化学报告。©2022普罗斯科学。版权所有。
{"title":"American Chemical Society - 263rd National Meeting and Exposition. Virtual/San Diego - March 20-24, 2022","authors":"A. Fernández-Llamazares, S.K. Chadrasekaran, P. Cole, X. Bofill","doi":"10.1358/dof.2022.47.5.3432776","DOIUrl":"https://doi.org/10.1358/dof.2022.47.5.3432776","url":null,"abstract":"The American Chemical Society (ACS)'s National Meeting and Exposition is a premier networking and education event for the global chemistry community, with an astounding program of scientific sessions covering all fields of chemistry. The 263rd edition of ACS meeting, with the theme 'Bonding through chemistry,' was held both on site at the San Diego Convention Center and virtually allowing for an almost return to normal meeting attendance since the start of the COVID-19 pandemic. The meeting spanned over 5 days of sessions comprising 11,359 s programmed with 9,282 in-person registrants and 3,284 virtual registrants. Posters and oral presentations were either in person, virtual or both, with live interaction possible either in a room and/or online. This report highlights some of the medicinal chemistry presentations delivered at the meeting. © 2022 Prous Science. All rights reserved.","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66444236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lenadogene nolparvovec. rAAV2 gene therapy vector encoding ND4, Treatment of Leber hereditary optic neuropathy Lenadogene nolparvovec。编码ND4的rAAV2基因治疗载体，治疗Leber遗传性视神经病变
IF 0.2 4区 医学 Q4 Medicine
Drugs of The Future
Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.6.3413456
L. Ferro Desideri, C. Traverso, M. Iester
{"title":"Lenadogene nolparvovec. rAAV2 gene therapy vector encoding ND4, Treatment of Leber hereditary optic neuropathy","authors":"L. Ferro Desideri, C. Traverso, M. Iester","doi":"10.1358/dof.2022.47.6.3413456","DOIUrl":"https://doi.org/10.1358/dof.2022.47.6.3413456","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66444385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pipeline on the Move - September 2022 管道在移动- 2022年9月
IF 0.2 4区 医学 Q4 Medicine
Drugs of The Future
Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.9.3474004
L.F. Betolin
{"title":"Pipeline on the Move - September 2022","authors":"L.F. Betolin","doi":"10.1358/dof.2022.47.9.3474004","DOIUrl":"https://doi.org/10.1358/dof.2022.47.9.3474004","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66446154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tanfanercept. Recombinant variant of human TNFR1, TNF-alpha modulator, Treatment of dry eye disease Tanfanercept。重组人TNFR1变异体，tnf - α调节剂，治疗干眼症
IF 0.2 4区 医学 Q4 Medicine
Drugs of The Future
Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.7.3413463
F. Biagini, L. Ferro Desideri, G. Giannaccare, C. Traverso, A. Vagge
{"title":"Tanfanercept. Recombinant variant of human TNFR1, TNF-alpha modulator, Treatment of dry eye disease","authors":"F. Biagini, L. Ferro Desideri, G. Giannaccare, C. Traverso, A. Vagge","doi":"10.1358/dof.2022.47.7.3413463","DOIUrl":"https://doi.org/10.1358/dof.2022.47.7.3413463","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66444898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paxalisib. PI3K/mTOR inhibitor, Treatment of gliomas Paxalisib。PI3K/mTOR抑制剂，治疗胶质瘤
IF 0.2 4区 医学 Q4 Medicine
Drugs of The Future
Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.1.3349022
Q. Chen, J. Wu, L. Tao, C. Ashby, L. Lin, Z. Chen
{"title":"Paxalisib. PI3K/mTOR inhibitor, Treatment of gliomas","authors":"Q. Chen, J. Wu, L. Tao, C. Ashby, L. Lin, Z. Chen","doi":"10.1358/dof.2022.47.1.3349022","DOIUrl":"https://doi.org/10.1358/dof.2022.47.1.3349022","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66440861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
American Heart Association (AHA) Scientific Sessions - 2021 Annual Meeting. Virtual - November 13-15, 2021 美国心脏协会(AHA)科学会议- 2021年年会。虚拟- 2021年11月13日至15日
IF 0.2 4区 医学 Q4 Medicine
Drugs of The Future
Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.3.3393248
N. Díaz
The AHA Scientific Sessions, the annual meeting of the Amer-ican Heart Association, highlights the latest cutting-edge basic, translational and clinical research in cardiovascular diseases. This year, the conference took place virtually due to the COVID-19 pandemic and comprised several days of live sessions and on-demand virtual content, including posters and prerecorded presentations.
美国心脏协会科学会议是美国心脏协会的年度会议，重点介绍心血管疾病的最新前沿基础、转化和临床研究。今年，由于2019冠状病毒病大流行，会议以虚拟方式举行，包括几天的现场会议和点播虚拟内容，包括海报和预先录制的演讲。
{"title":"American Heart Association (AHA) Scientific Sessions - 2021 Annual Meeting. Virtual - November 13-15, 2021","authors":"N. Díaz","doi":"10.1358/dof.2022.47.3.3393248","DOIUrl":"https://doi.org/10.1358/dof.2022.47.3.3393248","url":null,"abstract":"The AHA Scientific Sessions, the annual meeting of the Amer-ican Heart Association, highlights the latest cutting-edge basic, translational and clinical research in cardiovascular diseases. This year, the conference took place virtually due to the COVID-19 pandemic and comprised several days of live sessions and on-demand virtual content, including posters and prerecorded presentations.","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66443342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tebipenem pivoxil hydrobromide. Penicillin-binding protein (PBP) (bacterial) inhibitor, Carbapenem antibiotic, Treatment of urinary tract infections 氢溴化特比苯南酯。青霉素结合蛋白(PBP)(细菌)抑制剂，碳青霉烯类抗生素，尿路感染的治疗
IF 0.2 4区 医学 Q4 Medicine
Drugs of The Future
Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.5.3293606
M. N. Ahmad, C. Dasgupta, S. Chopra
{"title":"Tebipenem pivoxil hydrobromide. Penicillin-binding protein (PBP) (bacterial) inhibitor, Carbapenem antibiotic, Treatment of urinary tract infections","authors":"M. N. Ahmad, C. Dasgupta, S. Chopra","doi":"10.1358/dof.2022.47.5.3293606","DOIUrl":"https://doi.org/10.1358/dof.2022.47.5.3293606","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66443457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ciltacabtagene autoleucel. CAR-T therapy targeting B-cell maturation antigen (BCMA), Treatment of multiple myeloma Ciltacabtagene autoleucel。靶向b细胞成熟抗原(BCMA)的CAR-T疗法，治疗多发性骨髓瘤
IF 0.2 4区 医学 Q4 Medicine
Drugs of The Future
Pub Date : 2022-01-01 DOI: 10.1358/dof.2022.47.4.3381589
S. Lee, A. Cowan
{"title":"Ciltacabtagene autoleucel. CAR-T therapy targeting B-cell maturation antigen (BCMA), Treatment of multiple myeloma","authors":"S. Lee, A. Cowan","doi":"10.1358/dof.2022.47.4.3381589","DOIUrl":"https://doi.org/10.1358/dof.2022.47.4.3381589","url":null,"abstract":"","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66443544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
类型
全部 化学•材料 生命科学 医学 物理 工程技术 环境•农林 材料科学 地球科学 法学 管理学 化学 环境科学与生态学 计算机科学 教育学 经济学 农林科学 人文科学 生物学 数学 物理与天体物理 心理学 综合性期刊 其他 工业工程 理学 历史学 农学 文学 信息工程
数据库
全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley
期刊
Drugs of The Future
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们：info@booksci.cn
Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1